The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Human mast cells express corticotropin‐releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor
Abstract
Mast cells are critical for allergic reactions, but also for innate or acquired immunity and inflammatory conditions that worsen by stress. Corticotropin-releasing hormone (CRH), which activates the hypothalamic-pituitary-adrenal axis under stress, also has proinflammatory peripheral effects possibly through mast cells. We investigated the expression of CRH receptors and the effects of CRH in the human leukemic mast cell (HMC-1) line and human umbilical cord blood-derived mast cells. We detected mRNA for CRH-R1α, 1β, 1c, 1e, 1f isoforms, as well as CRH-R1 protein in both cell types. CRH-R2α (but not R2β or R2γ) mRNA and protein were present only in human cord blood-derived mast cells. CRH increased cAMP and induced secretion of vascular endothelial growth factor (VEGF) without tryptase, histamine, IL-6, IL-8, or TNF-α release. The effects were blocked by the CRH-R1 antagonist antalarmin, but not the CRH-R2 antagonist astressin 2B. CRH-stimulated VEGF production was mediated through activation of adenylate cyclase and increased cAMP, as evidenced by the fact that the effect of CRH was mimicked by the direct adenylate cyclase activator forskolin and the cell-permeable cAMP analog 8-bromo-cAMP, whereas it was abolished by the adenylate cyclase inhibitor SQ22536. This is the first evidence that mast cells express functional CRH receptors and that CRH can induce VEGF secretion selectively. CRH-induced mast cell-derived VEGF could, therefore, be involved in chronic inflammatory conditions associated with increased VEGF, such as arthritis or psoriasis, both of which worsen by stress.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, mast cells express receptors for CRH 207 , 208 that may act in an antagonistic fashion. Signaling via CRH1 receptors triggers mast cell degranulation, 205 whereas signaling through CRH2 receptors does not. 209”
From Mast cell ontogeny: From fetal development to life‐long health and disease (2023) · cites this paper as [207]
Citations
Cites
The Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated Inflammation
Chrousos, G. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322008 · Cited by 2,579
Xia, Y.-P., Li, B., Hylton, D., Detmar, M., Yancopoulos, G. D., & Rudge, J. S. (2003) · Blood · doi:10.1182/blood-2002-12-3793 · Cited by 367
Research works printed but not linked: 63
- 2000, Clin. Exp. Allergy, 1205
- 2002, Trends Immunol., 425
- 2004, J. Neuroimmunol., 1
- 1995, N. Engl. J. Med., 1351
- 1998, Endocrinology, 403
- 2004, Trends Pharmacol. Sci., 563
- 1993, Proc. Natl. Acad. Sci. USA, 8967
- 1996, Endocrinology, 72
- 1995, Proc. Natl. Acad. Sci. USA, 836
- 1993, FEBS Lett., 1
- 2002, Trends Endocrinol. Metab., 436
- 1994, Biochem. Biophys. Res. Commun., 1836
- 2001, FASEB J., 2754
- 1994, Chromosome Res., 471
- 1997, Biochim. Biophys. Acta, 129
- 1998, Mol. Endocrinol., 1077
- 1995, Proc. Natl. Acad. Sci. USA, 1108
- 1990, Endocrinology, 440
- 1988, Immunol. Lett., 5
- 1991, Cell Immunol., 77
- 2003, Pain, 297
- 2001, Arthritis Rheum., 1761
- 1999, Brain Behav. Immunity, 225
- 1999, Am. J. Physiol., G391
- 1996, Am. J. Physiol., G884
- 2002, APMIS, 355
- 1998, J. Exp. Med., 1135
- 1998, Mol. Biol. Cell., 875
- 2004, Endocrinology, 43
- 1999, Blood, 3338
- 2000, In Vitro Cell. Dev. Biol. Anim., 211
- 2000, Placenta, 32
- 1961, Biochim. Biophys. Acta, 364
- 2001, In Vitro Cell. Dev. Biol. Anim., 50
- 1998, Endocrinology, 566
- 1999, J. Neurochem., 388
- 1999, Mol. Endocrinol., 2189
- 1995, Biochem. Biophys. Res. Commun., 1015
- 2004, Eur. J. Biochem., 2821
- 2003, Brain Res., 192
- 2003, J. Clin. Endocrinol. Metab., 363
- 1997, J. Recept. Signal Transduct. Res., 647
- 1995, Eur. J. Endocrinol., 591
- 1998, J. Neurosci. Res., 507
- 1987, J. Biol. Chem., 12893
- 1998, Inflamm. Res., 245
- 2004, J. Immunol., 1227
- 1994, J. Leukocyte Biol., 410
- 2000, Inflamm. Res., 86
- 1991, J. Immunol., 4222
- 1992, Trends Biochem. Sci., 418
- 1991, Science, 421
- 1999, Int. J. Immunopathol. Pharmacol., 7
- 2003, Blood, 161
- 1995, Chem. Immunol., 84
- 2004, Blood, 1048
- 2001, Urology, 47
- 2004, J. Urol., 945
- 2001, Ann. Rheum. Dis., 187
- 1996, Endocr. J., 241
- 2002, J. Rheumatol., 39
- 2003, Mast cells and corticotropin-releasing hormone (CRH) are required for experimental inflammatory arthritis, C44
- 2002, J. Rheumatol., 1252
Cited by
Sorted by citations
Petra, A. I., Panagiotidou, S., Hatziagelaki, E., Stewart, J. M., Conti, P., & Theoharides, T. C. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.04.002 · Cited by 592
Self-citationMast Cells, Mastocytosis, and Related Disorders
Theoharides, T. C., Valent, P., & Akin, C. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1409760 · Cited by 518
Self-citationKey role of CRF in the skin stress response system
Slominski, A. T., Zmijewski, M. A., Zbytek, B., Tobin, D. J., Theoharides, T. C., & Rivier, J. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1092 · Cited by 400
Self-citationCorticotropin releasing hormone and the skin
Slominski, A. (2006) · Frontiers in bioscience · doi:10.2741/1966 · Cited by 157
Mast cell activation and autism
Theoharides, T. C., Angelidou, A., Alysandratos, K.-D., Zhang, B., Asadi, S., Francis, K., Toniato, E., & Kalogeromitros, D. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.12.017 · Cited by 125
Self-citationNeuroendocrine–immune disequilibrium and endometriosis: an interdisciplinary approach
Tariverdian, N., Theoharides, T. C., Siedentopf, F., Gutiérrez, G., Jeschke, U., Rabinovich, G. A., Blois, S. M., & Arck, P. C. (2007) · Seminars in Immunopathology · doi:10.1007/s00281-007-0077-0 · Cited by 120
Self-citationTeitelbaum, A. A., Gareau, M. G., Jury, J., Yang, P. C., & Perdue, M. H. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90210.2008 · Cited by 116
The bidirectional communication between neurons and mast cells within the gastrointestinal tract
Van Nassauw, L., Adriaensen, D., & Timmermans, J.-P. (2007) · Autonomic Neuroscience · doi:10.1016/j.autneu.2006.10.003 · Cited by 99
Vicario, M., Alonso, C., Guilarte, M., Serra, J., Martínez, C., González-Castro, A. M., Lobo, B., Antolín, M., Andreu, A. L., García-Arumí, E., et al. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.05.005 · Cited by 92
Mast Cells in Allergic and Inflammatory Diseases
Sismanopoulos, N., Delivanis, D.-A., Alysandratos, K.-D., Angelidou, A., Therianou, A., Kalogeromitros, D., & C. Theoharides, T. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212800165997 · Cited by 87
Mast cells in chronic inflammation, pelvic pain and depression in women
Graziottin, A., Skaper, S. D., & Fusco, M. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2014.911280 · Cited by 63
Hatziagelaki, E., Adamaki, M., Tsilioni, I., Dimitriadis, G., & Theoharides, T. C. (2018) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.250845 · Cited by 62
Mast cell ontogeny: From fetal development to life‐long health and disease
Chia, S. L., Kapoor, S., Carvalho, C., Bajénoff, M., & Gentek, R. (2023) · Immunological Reviews · doi:10.1111/imr.13191 · Cited by 60
Corticotropin releasing factor promotes breast cancer cell motility and invasiveness
Androulidaki, A., Dermitzaki, E., Venihaki, M., Karagianni, E., Rassouli, O., Andreakou, E., Stournaras, C., Margioris, A. N., & Tsatsanis, C. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-30 · Cited by 58
Singh, L., Kaur, A., Bhatti, M. S., & Bhatti, R. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02805-5 · Cited by 55
Stress-related changes in oesophageal permeability: filling the gaps of GORD?: Figure 1
Söderholm, J. D. (2007) · Gut · doi:10.1136/gut.2007.120691 · Cited by 25
Metadata
- Authors
- Cao, J., Papadopoulou, N., Kempuraj, D., Boucher, W. S., Sugimoto, K., Cetrulo, C. L., & Theoharides, T. C.
- Affiliations
- Department of Biochemistry, Tufts-New England Medical Center , Boston, MA 02111
- Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine, Tufts-New England Medical Center , Boston, MA 02111
- Department of Obstetrics and Gynecology, Tufts-New England Medical Center , Boston, MA 02111
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-06
- Volume
- 174
- Issue
- 12
- Pages
- 7665-7675
- ISSN
- 0022-1767
- 1550-6606
- Cited by
- 285
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review